Browse the detailed record of transactions filed by Gay John M., 首席财务官. Director active across 1 company, notably Novan, Inc.. Aggregated, 1 reports have been published. Split: 1 buy · 0 sell. Total volume traded: €3k. History available since 18 March 2022. The latest transaction was filed on 18 March 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
John M. Gay is the Chief Financial Officer at Novan, Inc., a biopharmaceutical company. He is responsible for financial management and strategy for the company. With a strong background in the healthcare sector, John plays a key role in strategic financial decision-making. His expertise in finance and regulation is essential to support Novan's growth.